Peptonic Medical AB (publ) (“Peptonic” or the “Company”) announces that the Uppsala District Court today, on 19 September 2025, has approved the Company’s request to
Peptonic Medical AB (publ) (“Peptonic” or the “Company”) has today submitted a request to the Uppsala District Court to extend the ongoing corporate reconstruction by
Peptonic Medical AB (publ) (“Peptonic” or the “Company”) today announces that Anna Linton, at her own request, resigns from her role as Chief Executive Officer.
The annual general meeting in PEPTONIC medical AB (the “Company”) was held today, 26 June 2025, at Eversheds Sutherland Advokatbyrå’s premises at Sveavägen 20 in
On 23 May 2025, PEPTONIC medical AB (“Peptonic” or the “Company”) issued a notice to the annual general meeting to be held on 26 June
Peptonic Medical AB (publ) (“Peptonic” or the “Company”) announces that the Uppsala District Court has today, June 17 2025, approved the Company’s request to extend
